Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
455 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2024-04-26 (expresspharma.in)
Parexel partners with Palantir to accelerate clinical data delivery
Under the collaboration, Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform, focused on driving clinical trial efficiency while maintaining the safety and regulatory rigor
Read more
2020-11-23 (globenewswire.com)
Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials
BOSTON and DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of...
Read more
(informa.com)
Singin' the CRO Blues
The big three CROs--Quintiles, Parexel, & Covance have suffered contract cancellations, less-than-glowing earnings reports, and diving stock prices over the last 12 months. But, while the near-term continues to look fairly bleak, there's cause for hope on the horizon. CROs are increasingly seen as
Read more